Browse > Article
http://dx.doi.org/10.7841/ksbbj.2012.27.2.121

Structural Requirements of Minoxidil Analogs for Enhancing Lysyl Hydroxylase Inhibitory Activity  

Myung, Pyung-Keun (College of Pharmacy, Chungnam National University)
Sung, Nack-Do (College of Agriculture and Life Science, Chungnam National University)
Lee, Jae-Heung (School of Mechanical Engineering, Korea University of Technology and Education)
Publication Information
KSBB Journal / v.27, no.2, 2012 , pp. 121-126 More about this Journal
Abstract
In order to explore structural features of minoxidil analogs with a view of enhancing lysyl hydroxylase (LH) inhibitory activity, molecular holographic QSAR (HQSAR) and CoMSIA (comparative molecular similarity indices analysis) were performed. The results from the atomic contributions with optimized the HQSAR 6-2 model indicated that, in case of pyrimidine-1-N-oxide substituent, C2 atom of pyrimidine ring and C'3-C'4 bond of 4-piperidinol group showed the highest impact on the inhibitory activity towards LH enzyme. It was also evident from the information of the optimized CoMSIA F5 model that the inhibitory activity mainly depended on the hydrophobic field contribution (36%) and the hydrogen bond (H-bond) field contribution (49.2%) of substrate molecule. Particularly, it is predicted that the functional groups which disfavor H-bond acceptors in large space around the piperidinol group and also the functional groups which favor the H-bond acceptors at C'4 (& C'5) atom in $R_5$ group play a role for increased inhibitory activity. With this in mind, it is likely that a novel candidate having more improved inhibitory activity on hair growth could be designed in the future.
Keywords
Minoxidil analogs; HQSAR; CoMSIA; Lysyl hydroxylase; Hair growth agent;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Murad, S., M. C. Tennant, and S. R. Pinnell (1992) Structure-activity relationship of minoxidil analogs as inhibitors of lysyl hydroxylase in cultured fibroblasts. Arch. Biochem. Biophys. 292: 234-238.   DOI
2 Murad, S., L. C. Walker, S. Tajima, and S. R, Pinnell (1994) Minimum structural requirements for minoxidil inhibition of lysyl hydroxylase in cultured fibroblasts. Arch. Biochem. Biophy. 308: 42-47.   DOI
3 Sung, N. D. and J. H. Park (2011) 3D-QSAR analysis and molecular docking of thiosemicarbazone analogues as a potent tyrosinase inhibitor. Bull. Korean Chem. Soc. 32: 1241-1248.   과학기술학회마을   DOI
4 Tong, W., D. R. Lowis, R. Perkins, Y. Chen, W. J. Welsh, D. W. Goddette, T. W. Heritage, and D. M. Sheehan (1998) Evaluation of quantitative structure-activity relationship methods for largescale prediction of chemicals binding to the estrogen receptor. J. Chem. Inf. Comput. Sci. 38: 669-67.   DOI
5 Micheal, S., B. T. David, and W. Peter (1999) Effect of parameter variations on the effectiveness of HQSAR analyses, Quant. Struc-Act. Relat. 18: 245-252.   DOI
6 Schneider, G. and K. H. Baringhause (2008) Molecular design; Concepts and applications. pp. 64-65. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany.
7 Zuurmond, A. M., A. J. Verhoeven, E. A. Dura, J. D. Groot, and R. A. Bank (2004) Minoxidil exerts different effects on gene expression of lysyl hydroxylase 1, 2, and 3: Implications for collagen cross-linking and treatment of fibrosis. Matrix Biol. 24: 261-270.
8 Trueb, R. M. (2001) The value of hair cosmetics and pharmaceuticals. Dermatology 202: 275-282.   DOI
9 Murad, S. and S. R. Pinnell (1987) Suppression of fibroblast proliferation and lysyl hydroxylase activity by minoxidil. J. Biol. Chem. 262: 11973-11978.
10 Hautala, T., J. Heikkinen, K. I. Kivirikko, and R. Myllyla (1992) Minoxidil specifically decreases the expression of lysine hydroxylase in cultured human skin fibroblasts. Biochem. J. 283: 51-54.   DOI
11 Heritage, T. W. and D. R. Lowis (1999) Molecular hologram QSAR, pp. 212-225. In: A. S. Parrill, and M. R. Reddy (eds.), Rational drug design: Novel Methodology and Practical Applications, ACS Symposium Series, USA.
12 Kim, S. J. and N. D. Sung (2011) CoMFA analysis on the inhibitory activity against lysyl hydroxylase of minoxidil analogues. J. Korean Soc. Cosm. 17: 753-758.
13 Passoja, K., K. Rautavuoma, L. Ala-Kokko, T. Kosonen, and K. I. Kivirikko (1998) Cloning and characterization of a third human lysyl hydroxylase isoform. Proc. Natl. Acad. Sci. USA. 95: 10482-10486.   DOI   ScienceOn
14 Hansch, C. (1969) A quantitative approach to biochemical structure-activity relationships. Acc. Chem. Res. 2: 232-239.   DOI
15 Klebe, G., U. Abraham, and T. Mietzner (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 37: 4130-4146.   DOI   ScienceOn
16 Tripos Associates, Inc., 1699 S. Hanley Road, Suite 303, St. Louis, MO 63144-2913, USA. http://www.tripos.com/Bookshelf/hqsar. (2006).
17 Zappacosta, A. R. (1980) Reversal of baldness in patient receiving minoxidil for hypertension. N. Engl. J. Med. 303: 1480-1481.
18 Suzuki, M. (2008) Hair loss mechanisms and treatment materials: A review. Cosmetics Toiletries 123: 51-58.
19 Buhl, A. E., S. J. Conrad, and D. J. Waldon (1993) Potassium channel conductance as a control mechanism in hair follicles. J. Invest. Dermatol. 101: 148-152.   DOI
20 Meisheri, K. D., G. A. Johnson, and L. Puddington (1993) Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidil. Biochem. Pharmacol. 45: 271-279.   DOI
21 Messenger, A. G. and J. Rundegren (2004) Minoxidil: mechanisms of action on hair growth. Br. J. Dermatol. 150: 186-194.   DOI   ScienceOn
22 Samimi, A. and J. A. Last (2001) Mechanism of inhibition of lysyl hydroxylase activity by the organophosphates malathion and malaoxon. Toxicol. Appl. Pharmacol. 176: 181-186.   DOI
23 Walker, L. C., M. A. Overstreet, and H. N. Yeowell (2005) Tissue-specific expression and regulation of the alternatively-spliced forms of lysyl hydroxylase 2 (LH2) in human kidney cells and skin fibroblasts. Matrix Biol. 23: 515-523.   DOI
24 Gelse, K., E. Poschl, and T. Aigner (2003) Collagens-structure, function, and biosynthesis. Adv. Drug Deliv. Rev. 55: 1531-1546.   DOI   ScienceOn